Patient Education Sheet Library
Search Results
Azacitidine and Venetoclax
The combination of azacitidine and venetoclax is used for acute myeloid leukemia (AML).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Download (English) – 0.37 MBDownloads:
Ziftomenib
Ziftomenib is used for acute myeloid leukemia (AML) with a nucleophosmin 1 (NPM1) mutation.
Treatment Taken by MouthDownloads:
Sevabertinib
Sevabertinib is used for certain types of lung cancer with certain abnormal human epidermal growth…
Treatment Taken by MouthDownloads:
Downloads:
Encorafenib, Cetuximab and FOLFOX
The combination of encorafenib, cetuximab, and FOLFOX (leucovorin, fluorouracil (5-FU), and oxaliplatin) is used for…
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Talazoparib and Enzalutamide
The combination of talazoparib and enzalutamide is used for certain types of prostate cancer.
Treatment Taken by MouthDownloads:
Downloads:
Abiraterone and Prednisone
The combination of abiraterone and prednisone is used for prostate cancer.
Treatment Taken by MouthDownloads:
Abiraterone (Micronized Formulation) and Methylprednisolone
The combination of abiraterone (micronized formulation) and methylprednisolone is used for prostate cancer.
Treatment Taken by MouthDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
